Charity Scripture

Affiliations

AbbVie Stemcentrx LLC, South San Francisco, CA, USA.

Publications (1)

Phase I safety and pharmacokinetics study of rovalpituzumab tesirine in Japanese patients with advanced, recurrent small cell lung cancer.

Lung cancer (Amsterdam, Netherlands)

Avec: Hibiki Udagawa , Hiroaki Akamatsu , Kentaro Tanaka , Masayuki Takeda , Shintaro Kanda , Keisuke Kirita , Shunsuke Teraoka , Kazuhiko Nakagawa , Yutaka Fujiwara , Ikuko Yasuda , Sumiko Okubo , Masayuki Shintani , Matthew P Kosloski , Charity Scripture , Tomohide Tamura , Isamu Okamoto

Réseau de co-auteurs

Hibiki Udagawa 1 collaboration

Hiroaki Akamatsu 1 collaboration

Kentaro Tanaka 1 collaboration

Masayuki Takeda 1 collaboration

Shintaro Kanda 1 collaboration

Keisuke Kirita 1 collaboration

Shunsuke Teraoka 1 collaboration

Kazuhiko Nakagawa 1 collaboration

Yutaka Fujiwara 1 collaboration

Ikuko Yasuda 1 collaboration

Sumiko Okubo 1 collaboration

Masayuki Shintani 1 collaboration

Matthew P Kosloski 1 collaboration

Tomohide Tamura 1 collaboration

Isamu Okamoto 1 collaboration